Curaleaf Records $317.1 Million In Q3 2021 Revenue, Net Loss

Curaleaf Holdings (CSE: CURA) this evening reported its third quarter 2021 financial results, posting revenues of $317.1 million for the quarter along with a net loss of $59.3 million. Adjusted EBITDA for the period came in at $71.4 million.

Revenues were up a marginal 2% on a quarter over quarter basis from $312.2 million, perhaps indicating why the company continues to acquire firms to achieve inorganic growth. On a year over year basis revenues were up 74% meanwhile, from $182.4 million.

Gross profits came in at $144.9 million for the quarter before the impact of fair value adjustments, following $172.2 in cost of goods sold. Operating expenses meanwhile totaled $142.7 million, lead by selling, general and administrative expenses of $101.8 million for the quarter. Following the impact of fair value gains on biological assets, the company posted an income from operations of $40.0 million.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Other expenses then turned the quarter negative however, with a total of $39.0 million in other expenses recorded. Included within the figure is interest expenses of $15.7 million, interest expense related to lease liabilities of $9.5 million, other expenses of $8.2 million and impairment of intangibles to the tune of $5.7 million.

Overall, after tax expenses of $60.3 million, the company posted a net loss of $59.3 million.

Looking to the balance sheet, the company currently has a cash position of $317.2 million, along with inventory of $346.2 million. Total current assets overall are currently pegged at $906.5 million. Accounts payable meanwhile are sitting at $60.8 million, while income tax payable is sitting at $130.1 million. Current liabilities overall are at $335.2 million.

Finally, the company indicated that they remain on track to hit prior guidance of $1.2 to $1.3 billion in FY2021 revenues, “albeit at the lower end of the range.”

Curaleaf Holdings last traded at $12.80 on the CSE.


Information for this briefing was found via Sedar and Curaleaf Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Curaleaf Closes $1.1 Billion Acquisition of Grassroots

Curaleaf Holdings (CSE: CURA) announced this morning that it has finally completed its acquisition of...

Thursday, July 23, 2020, 09:15:57 AM

TerrAscend Acquires Maryland Assets From Curaleaf In US$27.5 Million Deal

Curaleaf Holdings (CSE: CURA) apparently is looking to dispose assets. It was announced this morning...

Friday, November 6, 2020, 07:26:47 AM

Curaleaf Opens Cannabis Dispensary in Provincetown, Massachusetts

Curaleaf Holdings Inc. (TSX: CURA) has announced its new retail dispensary in Cape Cod, Massachusetts...

Wednesday, January 29, 2020, 10:48:46 AM

Curaleaf Opens Its 100th Retail Cannabis Location

Curaleaf Holdings (CSE: CURA) this morning achieved a milestone, with company opening its 100th national...

Wednesday, February 10, 2021, 09:07:35 AM

Curaleaf Seeks Reorganization Of US Assets To List On TSX

Curaleaf Holdings (CSE: CURA) is looking to be the second multi-state cannabis operator to list...

Monday, July 17, 2023, 07:43:04 PM